π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This study will assess the safety, atorvastatin pharmacokinetics, and LDL-C...
Status
Completed
Location
Multiple Locations
Start Date
2012-12
Trial ID
NCT01779453
Treatments Being Tested
Dyslipidemia (DL) is a metabolic disorder characterized by an imbalance of ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-15
Trial ID
NCT07624604
Treatments Being Tested
Tuberculosis (TB) is caused by mycobacterial organism. It is the leading in...
Status
Recruiting
Location
National Tuberculosis Reference Laboratory
Start Date
2024-01-03
Trial ID
NCT06199921
Atherosclerosis is a condition that occurs when fatty deposits build up alo...
Status
Completed
Location
University of Southern California
Start Date
2001-05-01
Trial ID
NCT00715273
Treatments Being Tested
A Phase 1, Fixed-Sequence, Open-label Study in Healthy Subjects to Estimate...
Status
Completed
Location
Quintiles
Start Date
2015-12
Trial ID
NCT02641899
Treatments Being Tested
This phase II, open-label research study was conducted in 129 healthy volun...
Status
Completed
Location
University of Pennsylvania
Start Date
2006-03
Trial ID
NCT00359281
Treatments Being Tested
The study is prospective, open-label, randomized, single-center study invol...
Status
Unknown
Location
Samara Regional Cardiology Dispansery
Start Date
2022-09-02
Trial ID
NCT05624658
Treatments Being Tested
The purpose of this study is to assess pharmacokinetic parameters of atorva...
Status
Recruiting
Location
National Tuberculosis and Leprosy Training Centre, Saye
Start Date
2026-01-03
Trial ID
NCT07303699
This study aims first to assess the efficacy, safety, and effectiveness of ...
Status
Unknown
Location
SZUMC
Start Date
2020-03-28
Trial ID
NCT05925140
The purpose of this study is to explore the efficacy and safety of Atorvast...
Status
Completed
Location
King Fahad Medical City
Start Date
2014-01-01
Trial ID
NCT02029573
Treatments Being Tested